Andere Sprachen Charmacy Pharmaceutical Co., Ltd.

Aktien

A3EJ05

CNE1000023D6

2289

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:09:00 03.05.2024			% 5 Tage	% 1. Jan.
13,4 ^HKD	-4,15 %		-3,87 %	+3,40 %

01.04.	Charmacy Pharmaceutical 2023 Gewinn sinkt aufgrund geringerer Gewinne aus der Veräußerung von Vermögenswerten	MT
28.03.	Charmacy Pharmaceutical Co. Ltd. schlägt Schlussdividende für das am 31. Dezember 2023 beendete Geschäftsjahr vor, zahlbar am 10. Juli 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	01.04.
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	28.03.
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023	18.03.
Charmacy Pharmaceutical Meets Minimum Public Float Norms	04.09.23
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	27.08.23
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023	05.06.23
Charmacy Pharmaceutical Chairman Steps Down	01.06.23
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes	01.06.23
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023	25.05.23
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%	19.04.23
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives	18.04.23
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023	31.03.23
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31.03.23
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder	03.03.23
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.	10.02.23
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.	17.01.23
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.	17.01.23
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit	21.12.22
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022	20.12.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Charmacy Pharmaceutical Co., Ltd.

Aktien

A3EJ05

CNE1000023D6

2289

Andere Sprachen

Filter